This National Cancer Institute grant is for the Pediatric Cancer Adoptive Cellular Therapy (Can-ACT) Network. It seeks UG3/UH3 applications to advance innovative cell therapy strategies into clinical trials for treating solid tumors in pediatric cancer patients (18 years or younger). The initiative aims to expand the existing Can-ACT Network, which focuses on developing cutting-edge cell therapy approaches for both pediatric and adult cancers. A key objective is to accelerate the transition of new cell therapy products to clinical testing through collaborative preclinical and translational research. The grant supports multi-investigator teams with the expertise needed to bring novel cell therapies to the clinic, ultimately improving treatment options for children with solid tumors.
Opportunity ID: 351341
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-24-021 |
| Funding Opportunity Title: | Cancer Adoptive Cellular Therapy Network (Can-ACT) for Pediatric Cancers (UG3/UH3 Clinical Trial Required) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.395 — Cancer Treatment Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 06, 2023 |
| Last Updated Date: | Dec 06, 2023 |
| Original Closing Date for Applications: | Mar 06, 2024 |
| Current Closing Date for Applications: | Mar 06, 2024 |
| Archive Date: | Apr 11, 2024 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $900,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | County governments Native American tribal governments (Federally recognized) City or township governments For profit organizations other than small businesses Small businesses Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Special district governments Others (see text field entitled “Additional Information on Eligibility” for clarification) State governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Independent school districts Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The National Cancer Institute (NCI) intends to promote a new initiative by publishing a Notice of Funding Opportunity (NOFO) soliciting UG3/UH3 applications for the pediatric arm of the Cancer Adoptive Cellular Therapy (Can-ACT) Network. The overall goal of the NOFO is to advance new cell therapy strategies into clinical testing for the treatment of solid tumors in pediatric cancer patients (18 years or younger). The successful applications will add to -the newly established Cancer Adoptive Cellular Therapy (Can-ACT) Network, dedicated to developing innovative cell therapy approaches for the treatment of solid tumors in pediatric and adult tumors. The emphasis is on accelerating the advancement of new cell therapy strategies into clinical testing through novel and collaborative approaches to preclinical testing and translational studies. Can-ACT will support multi-investigator teams with the relevant expertise, assembled to bring new cell therapy products to the clinic. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-24-021.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 351341 Full Announcement-RFA-CA-24-021 -> RFA-CA-24-021-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00284051 | Feb 06, 2024 | Mar 06, 2024 | View |
Package 1
Mandatory forms
351341 RR_SF424_5_0-5.0.pdf
351341 PHS398_CoverPageSupplement_5_0-5.0.pdf
351341 RR_OtherProjectInfo_1_4-1.4.pdf
351341 PerformanceSite_4_0-4.0.pdf
351341 RR_KeyPersonExpanded_4_0-4.0.pdf
351341 RR_Budget10_3_0-3.0.pdf
351341 PHS398_ResearchPlan_5_0-5.0.pdf
351341 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
351341 RR_SubawardBudget10_30_3_0-3.0.pdf
351341 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
